Although the recombinant anti-PD-1 Nb-Fc could not avoid tumor formation in Xenograft mice model, it could significantly delay tumor growth, indicating that the anti-PD-1 Nb-Fc could inhibit tumor growth invivo. Here, PDCD1 is linked to neoplasm.